The A.I. story nobody is telling you (Read ASAP)

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

Bradley J. Tandy net worth and biography

Bradley Tandy Biography and Net Worth

SVP of Colfax

Bradley J. Tandy serves as Senior Vice President, General Counsel of the Company. He has been Senior Vice President, General Counsel since July 2019. From February 2019 through June 2019, he served as our interim general counsel. Mr. Tandy also continues to serve in his capacity as Executive Vice President, General Counsel and Secretary of DJO. Prior to joining DJO, Mr. Tandy served as Senior Vice President, General Counsel and Secretary of Biomet, Inc. from 2006 through 2014. Prior to serving as General Counsel, Brad served as Vice President, Assistant General Counsel and Chief Compliance Officer of Biomet from 1999 through 2006. He joined Biomet as Assistant General Counsel in 1992. Prior to his employment at Biomet, Mr. Tandy was a partner in the law firm of Rasor, Harris, Lemon & Reed in Warsaw, Indiana, focusing his practice on representation of medical device and healthcare companies. He was an elected public official in Kosciusko County, Indiana, serving as a County Councilman for 22 years. He received his undergraduate degree in Political Science from DePauw University and earned his Doctorate of Jurisprudence at Indiana University School of Law in Bloomington, Indiana.

What is Bradley J. Tandy's net worth?: The estimated net worth of Bradley J. Tandy is at least $0.00 as of February 27th, 2023. Mr. Tandy owns 13,483 shares of Colfax stock worth more than $0 as of April 24th. This net worth estimate does not reflect any other assets that Mr. Tandy may own. Learn More about Bradley J. Tandy's net worth.
How do I contact Bradley J. Tandy?: The corporate mailing address for Mr. Tandy and other Colfax executives is 420 NATIONAL BUSINESS PARKWAY 5TH FLOOR, ANNAPOLIS JUNCTION MD, 20701. Colfax can also be reached via phone at (302) 252-9160 and via email at [email protected]. Learn More on Bradley J. Tandy's contact information.
Has Bradley J. Tandy been buying or selling shares of Colfax?: Bradley J. Tandy has not been actively trading shares of Colfax during the past quarter. Most recently, Bradley J. Tandy sold 1,498 shares of the business's stock in a transaction on Monday, March 7th. The shares were sold at an average price of $38.88, for a transaction totalling $58,242.24. Learn More on Bradley J. Tandy's trading history.
Who are Colfax's active insiders?: Colfax's insider roster includes Christopher Hix (CFO), Shyam Kambeyanda (EVP), Patricia Lang (SVP), Jason Maclean (SVP), Douglas Pitts (Insider), Daniel Pryor (EVP), Mitchell Rales (Director), Brady Shirley (CEO), Bradley Tandy (SVP), Matthew Trerotola (CEO), and Rajiv Vinnakota (Director). Learn More on Colfax's active insiders.

Bradley J. Tandy Insider Trading History at Colfax

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
3/7/2022	Sell	1,498	$38.88	$58,242.24
2/25/2022	Sell	656	$42.18	$27,670.08
2/23/2022	Sell	807	$41.83	$33,756.81

Bradley J. Tandy Buying and Selling Activity at Colfax

Colfax Company Overview

Colfax Corp. operates as a diversified technology company. The firm provides orthopedic care and fabrication technology products and services to customers. It operates through the following segments: Medical Technology and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

Today's Range

Now: N/A

50 Day Range

MA: $110.71

$39.06

$127.50

2 Week Range

Now: N/A

Volume

101,542 shs

Average Volume

1,387,519 shs

Market Capitalization

$6.30 billion

P/E Ratio

84.91

Dividend Yield

N/A

Beta

2.12